Stocks To Buy Now Blog

All posts by Christopher

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Targets a $393 Billion Heart Disease Problem with Epigenetics and AI

  • For cardiovascular conditions, annual health care costs are forecasted to increase from $393 billion in 2020 to $1.4 trillion by 2050, almost quadrupling in size.
  • What makes Cardio Diagnostics’ approach distinct, and what gives the company a defensible clinical position, is its ability to detect coronary heart disease earlier and with high sensitivity.
  • The company’s recent commercial and regulatory milestones give additional shape to the investment thesis.

Heart disease has held the grim distinction of being the leading cause of death in the United States for decades, and despite advances in medicine, the problem is getting worse, not better. According to the American Heart Association (“AHA”), cardiovascular disease accounted for more than 940,000 deaths in the United States in 2022, maintaining its position as the nation’s number one killer. Into that persistent and costly healthcare burden steps Cardio Diagnostics Holdings (NASDAQ: CDIO), a Chicago-based precision cardiovascular medicine company that is applying artificial intelligence, epigenetics and genetics to a problem that traditional diagnostic tools have never fully solved: detecting coronary heart disease, including forms that standard methods routinely miss, from a simple blood draw.

The scale of the problem that Cardio Diagnostics is working to address is difficult to overstate. According to the AHA, cardiovascular disease remains the leading cause of death across men, women, and most racial and ethnic groups in the nation, with one person dying every 34 seconds from the disease. 

The economic burden is equally staggering. For cardiovascular conditions, annual health care costs are forecasted to increase from $393 billion in 2020 to $1.4 trillion by 2050, almost quadrupling in size. In addition, productivity losses are estimated to increase by 54%, from $234 billion to $361 billion. For investors evaluating the size of the opportunity, that backdrop establishes a market driven not by discretionary healthcare spending but by a chronic, escalating, and unavoidable national health crisis.

What makes Cardio Diagnostics’ approach distinct, and what gives the company a defensible clinical position, is its ability to detect heart attack risk and coronary heart disease earlier and with high sensitivity. The company’s two flagship tests, Epi+Gen CHD and PrecisionCHD, were developed using the company’s proprietary AI-driven Multi-Omics Engine. These tests analyze a combination of DNA methylation biomarkers (epigenetic markers) and genetic markers, called single nucleotide polymorphisms (“SNPs”), from a blood sample. Artificial intelligence is then used to interpret these genetic and epigenetic signals and generate personalized insights related to heart attack risk and coronary heart disease detection.” 

Epi+Gen CHD assesses a patient’s three-year risk for a coronary heart disease event, including heart attacks. PrecisionCHD aids in the diagnosis and management of coronary heart disease. Both tests are noninvasive and require no fasting or radiation. They can also be performed in a doctor’s office or from an at-home sample collection kit ordered through a telemedicine platform, a meaningful advantage in terms of patient accessibility and clinician adoption. According to Cardio Diagnostics, PrecisionCHD has a sensitivity of better than 75% for both men and women.

Perhaps the most clinically significant aspect of the PrecisionCHD test is initial data supporting its ability to detect nonobstructive forms of coronary heart disease, specifically ischemia with no obstructive coronary arteries (“INOCA”) and myocardial infarction with no obstructive coronary arteries (“MINOCA”), which standard tools including angiograms typically can miss

Preliminary clinical data supporting this capability was presented at the American Heart Association Scientific Sessions in November 2025, where a University of Iowa collaboration study of 267 hospitalized acute coronary syndrome patients demonstrated that PrecisionCHD’s methylation indices could detect INOCA. For the millions of patients who present with symptoms but receive a clear angiogram, only to suffer subsequent cardiac events, this is the kind of breakthrough that the clinical community has been seeking.

The company’s recent commercial and regulatory milestones give additional shape to the investment thesis. In late 2024, Cardio Diagnostics received finalized CMS reimbursement rates of $854 for its clinical tests, along with dedicated CPT Proprietary Laboratory Analysis codes from the American Medical Association, both critical steps toward mainstream insurance coverage and broad clinical adoption. 

Cardio Diagnostics’ recent commercial and reimbursement milestones have helped strengthen its commercialization strategy. In December 2025, the company announced that the Centers for Medicare & Medicaid Services (“CMS”) finalized a gapfill reimbursement rate of $854 for both its Epi+Gen CHD and PrecisionCHD tests, effective for services provided on or after January 1, 2026. 

Earlier, the American Medical Association assigned dedicated CPT Proprietary Laboratory Analysis (“PLA”) codes to both tests: 0439U for Epi+Gen CHD and 0440U for PrecisionCHD. Those codes became effective in April 2024. Dedicated reimbursement codes and established CMS payment rates are important steps that can facilitate payer billing, reimbursement and broader clinical adoption.

In addition, the company expanded its provider network in October 2025, adding 15 new provider organizations across the United States. In January 2026, Cardio Diagnostics announced its first international expansion through a strategic agreement with Aimil Ltd. and Dr. Lal PathLabs to launch the PrecisionCHD test in India, a market where cardiovascular disease carries an enormous and growing burden. Dr. Lal PathLabs operates more than 290 clinical laboratories and a network of 300-plus MD pathologists, providing immediate infrastructure for meaningful scale.

Cardio Diagnostics has also established a multichannel commercialization strategy that extends beyond traditional clinical settings. The company is actively pursuing employer and benefits partnerships, and announced that it will exhibit at four national employee benefits conferences in June 2026, targeting employers, brokers, union trustees and plan administrators for whom cardiovascular disease represents one of the largest drivers of medical claims costs. Community-based programs further extend the company’s reach into patient populations that traditional clinical channels may not efficiently serve.

For investors evaluating the diagnostics landscape, Cardio Diagnostics occupies a position that is both scientifically grounded and commercially actionable: a proprietary, AI-driven platform with reimbursement milestones, growing provider adoption, growing evidence supporting the ability to detect what traditional tools miss, and a multi-channel strategy designed to reach patients through clinical, employer, and community pathways simultaneously. 

For more information, visit www.CDIO.ai.

NOTE TO INVESTORS: The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO

American Fusion(TM) Inc. (AMFN) Expands Patent Portfolio Targeting Future Commercial Texatron(TM) Fusion Engine(TM) Platform

  • American Fusion has filed a new patent application covering innovations expected to be incorporated into future commercial versions of its Texatron(TM) Fusion Engine(TM) platform.
  • Management believes the technologies disclosed in the filing could ultimately support hundreds of additional patent applications as the platform evolves, with a growing intellectual property portfolio focused on fusion energy generation, plasma control, system architecture, and energy-delivery technologies.
  • Through its wholly owned subsidiary, Kepler Fusion Technologies, American Fusion(TM) is pursuing a modular approach to fusion energy deployment, targeting industrial and commercial customers through behind-the-meter energy deployments before broader grid-scale applications.
  • The company is currently developing multiple Texatron(TM) Fusion Engine(TM) models, including 5-megawatt and 100-megawatt systems intended to support future commercialization efforts.

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, recently announced another step in its commercialization strategy with the filing of a new patent application covering innovations expected to be incorporated into future commercial versions of its Texatron(TM) Fusion Engine(TM) platform. According to the company, the application covers architectural and operational innovations currently being evaluated for future generations of the Texatron(TM) Fusion Engine(TM) following completion of Version 9 testing (https://ibn.fm/57OcR).

The filing represents the latest addition to a growing intellectual property portfolio that management views as an important component of long-term commercialization efforts.

“Intellectual property development remains a core pillar of our long-term strategy,” Executive Chairman Brent Nelson said in the company announcement. Management believes the technologies described within the latest application could ultimately support approximately 300 additional patent filings as future generations of the platform are developed. While those future filings remain prospective, the statement highlights the company’s emphasis on building a substantial intellectual property framework alongside ongoing engineering development.

Intellectual property often plays an important role in company valuations and competitive positioning in the fusion sector. Unlike traditional energy technologies, many fusion approaches rely on highly specialized reactor designs, plasma control systems, energy-delivery mechanisms, and supporting infrastructure. As a result, companies frequently seek broad patent protection around core technologies as they progress from prototype systems toward commercial deployment.

American Fusion(TM) states that its current intellectual property program spans technologies associated with fusion energy generation, plasma generation and control, system architecture, energy-delivery systems, and related platform innovations.

The company’s broader strategy reflects a growing trend within the fusion industry, where developers are increasingly focusing not only on technical milestones but also on protecting future commercial opportunities.

American Fusion(TM) emerged following the previously announced merger with Kepler Fusion Technologies, bringing the Texatron(TM) Fusion Engine(TM) platform under a publicly traded corporate structure. The company describes the Texatron(TM) Fusion Engine(TM) as a modular, infrastructure-grade fusion platform intended for industrial, commercial, and grid-constrained applications.

While fusion remains under development across the industry, American Fusion(TM) has articulated a commercialization strategy focused on scalable deployment rather than large, centralized facilities.

According to management, the company is currently developing nine Texatron(TM) Fusion Engine(TM) models and is constructing both a 5-megawatt demonstration system and a 100-megawatt commercial-scale design. The 100-megawatt system occupies a central role in the company’s commercialization plans.

Management has indicated that the modular architecture allows capacity to be expanded through standardized deployment. In practical terms, ten 100-megawatt units would provide approximately one gigawatt of generation capacity, creating a framework that can potentially be scaled over time as customer demand grows.

Rather than initially focusing on large utility-scale grid integration, American Fusion(TM) plans to pursue behind-the-meter deployments. This strategy involves placing generating assets directly at customer facilities, enabling industrial operators, manufacturers, data centers, and other large electricity users to access power generation on-site. Behind-the-meter deployment has become an increasingly discussed concept across the broader energy sector as companies seek greater control over energy costs, reliability, and infrastructure planning.

The company’s emphasis on modular deployment comes at a time when electricity demand forecasts continue to rise, driven by electrification trends, artificial intelligence infrastructure, advanced manufacturing, and data center expansion. These trends have renewed investor interest in a range of emerging energy technologies, including advanced nuclear systems, energy storage, and fusion.

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to AMFN are available in the company’s newsroom at https://ibn.fm/AMFN

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Closes in on Initial Production as Gold Prices Hold High

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

  • Near-term gold producer LaFleur Minerals is preparing to restart production at its Beacon Gold Mill located in the Abitibi Gold Belt, using a 100,000-metric tonne bulk sample from its nearby Swanson Gold Project as a feed source for its first gold pour
  • The company expects to benefit from market prices in the $4,400 to $4,500 range to generate healthy revenue above its $2,750-an-ounce base case with an all-in sustaining cost of just under $1,600 an ounce
  • LaFleur’s strategic acquisition of mining projects, development of its facilities, and plans for keeping its operation low-cost, underscores a recent agreement to increase the aggregate gross proceeds of a secured “bought deal” public offering

The gold market has obviously enjoyed a phenomenal year, trading broadly between $3,215 and $3,406 per troy ounce in May of last year, going on to hit its most recent apex near $5,600 in the early part of this year (https://ibn.fm/p5I1V). Market fluctuations have centered on the $4,400 to $4,500 range amid shifting central bank policies and international tensions, which have still allowed gold to hold at levels well above last year’s “record” highs (https://ibn.fm/liZOI).

The heady prices have enabled gold miners with break-even costs near $2,700 to post record profit margins, which has in turn fueled optimism in gold mining investment, including with leveraged exposure. Near-term gold producer LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) is on the cusp of beginning production with its Swanson Gold Project, nearby Beacon Gold Mill, and the newly acquired McKenzie East Gold Project — all situated in the prolific Abitibi Gold Belt in Québec. 

LaFleur’s nearly 22,400-hectare gold projects are previously operated sites conveniently accessed via over-the-road and rail line transportation within the Val-d’Or mining camp where labor and supply resources provide key support for mining operations in the Abitibi region. 

The company recently reported significant assay results from its ongoing drilling program at Swanson, including findings in four drill holes of 2.95 g/t Au over 80.00 meters, 2.37 g/t Au over 88.05 meters, 1.29 g/t Au over 93.85 meters, and 0.86 g/t Au over 103.55 meters plus 1.14 g/t Au over 56.65 meters (https://ibn.fm/ZjGMh).

LaFleur is actively working to resume gold production at the Beacon Gold Mill during the coming quarter after finalizing upgrades to the facility that will allow it to launch material processing at 750 metric tons per day (“TPD”), drawing on existing stockpiles on site and approximately 100,000 metric tons from a bulk sample for the company’s first gold pour and incrementally increasing capacity to 1,250 TPD. 

The company’s Preliminary Economic Assessment (“PEA”) completed in the spring anticipates a strong economic return from the operation.

“We’re looking at an all-in sustaining cost of just under $1,600 an ounce,” CEO and Director Paul Ténière told investors during a March 24 webinar. “This is at a base case of $2,750. Our technical report will be looking at a sensitivity of up-to-$5,000 gold. … We can certainly be running (our Swanson Gold Project) for the next few years and be a very cost-effective and profitable operation.”

Because of “significant investor demand,” LaFleur announced May 27 that it has agreed with Red Cloud Securities Inc. to increase the aggregate gross proceeds of a preciously secured “bought deal” public offering in which Red Cloud, as underwriter, will purchase units of LaFleur for potential resale as a public offering, as well as flow-through units of the company to be offered as charitable flow-through units in accord with Canada’s tax deduction laws (https://ibn.fm/mxprF).

The agreement increases the equity offerings from C$8 million to C$10 million, with potential gross proceeds of C$11.5 million if over-allotment and underwriter options are fully exercised, according to the news release. The net proceeds from the offerings will be used by the company to restart gold production operations at Beacon, continue exploration and drilling programs at Swanson and provide working capital for strategic acquisitions and other corporate purposes.

For more information, visit the company’s website at LaFleurMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to LFLRF are available in the company’s newsroom at https://ibn.fm/LFLRF

Qualified Person Statement:

All scientific and technical information contained in this article has been reviewed and approved by Louis Martin, P.Geo. (OGQ), Exploration Manager and Technical Advisor of the company and considered a Qualified Person for the purposes of NI 43-101.

HeartBeam Inc. (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection

  • The seriousness of coronary artery disease continues to intensify as populations age and cardiovascular risk factors become more common.
  • HeartBeam announced the launch of a pilot study focused on evaluating its on-demand 12-lead ECG patch in detecting coronary artery disease and inadequate blood flow and oxygen supply to tissue, or ischemia.
  • The study represents a significant step in the development of the HeartBeam patch, which has the potential to disrupt the $2 billion long-term continuous monitor and mobile cardiac telemetry (“MCT”) markets.

Coronary artery disease remains one of the most urgent and widespread health threats worldwide, contributing to millions of deaths each year and often progressing silently until a major cardiac event occurs. As healthcare providers search for faster and more accessible ways to identify high-risk patients earlier, HeartBeam (NASDAQ: BEAT) has launched a new pilot study designed to evaluate its technology — a proprietary on-demand 12-lead ECG patch — in detecting coronary artery disease and inadequate blood flow and oxygen supply to tissue, or ischemia. 

“Ischemia detection has not been possible on patch-based ambulatory monitors, and they do not provide clinical-grade insights over an extended period of time,” said HeartBeam CEO Robert Eno. “The HeartBeam patch is designed to change that. A device capable of generating an on-demand 12-lead ECG at the moment symptoms occur — wherever the patient may be — could fundamentally expand the role of ambulatory cardiac monitoring beyond rhythm assessment alone.”

The seriousness of coronary artery disease continues to intensify as populations age and cardiovascular risk factors become more common. According to the Centers for Disease Control and Prevention, coronary heart disease is the most common type of heart disease and was responsible for more than 900,000 deaths each year. The condition develops when plaque accumulates inside the coronary arteries, reducing blood flow to the heart and increasing the risk of chest pain, heart attacks and heart failure.

One of the most concerning aspects of coronary artery disease is that symptoms may not appear until the disease has significantly progressed. The American Heart Association notes that many patients experience warning signs intermittently or only during physical exertion, making diagnosis difficult if testing does not occur while symptoms are present. This challenge has fueled interest in portable cardiac technologies capable of capturing clinically relevant information outside hospitals and clinics.

The broader burden of cardiovascular disease further highlights the urgency surrounding coronary artery disease detection and treatment. The World Health Organization estimates that cardiovascular diseases account for approximately more than 19 million deaths globally each year, representing nearly one-third of all deaths worldwide. Delayed diagnosis remains a major factor contributing to poor outcomes, particularly among patients who do not seek immediate medical care when symptoms first appear.

Against this backdrop, the pilot study announced by HeartBeam “represents a significant step in the development of the HeartBeam patch, which has the potential to disrupt the long-term continuous monitor and mobile cardiac telemetry (“MCT”) markets,” the company stated, noting that patch-based ambulatory cardiac monitoring represents an approximate $2 billion market with established reimbursement pathways. 

“Entering a $2 billion market with established reimbursement is compelling on its own,” observed Eno. “Adding ischemia detection as a capability makes the opportunity significantly larger.”

According to the company, today’s ambulatory patch ECG monitors are limited to one to three leads and are primarily designed to assess heart rhythms, not ischemia. “As a result, patients experiencing intermittent chest pain or cardiac symptoms outside the clinic often cannot obtain a clinical-grade ECG at the moment symptoms occur,” the announcement stated.

The study, which will be conducted at two leading hospitals in Belgrade, Serbia, is designed to provide key data and information about the HeartBeam on-demand patch, which is currently investigational and not yet FDA-cleared. “The patch device follows HeartBeam’s credit card-sized device as the second form factor and leverages the same patented 3D ECG technology that captures the heart’s electrical signals from 3 noncoplanar dimensions,” the company explained. “The HeartBeam patch continuously records a single-lead ECG and enables patients to initiate a full synthesized 12-lead ECG recording on demand by placing two fingers on the device. This approach is intended to provide clinicians with high-quality cardiac insights when symptoms occur outside of traditional care settings.”

The pilot study will enroll approximately 50 patients who have a high risk of coronary artery disease and whose resting ECGs show no evidence of ischemia. During the study, each participant will undergo exercise stress testing, a standard diagnostic procedure used to identify ischemic changes. Immediately following the stress testing, patients will activate the HeartBeam patch to generate a synthesized 12-lead ECG, which will then be compared directly with a standard 12-lead ECG, which has been recorded at the same time. “The results will help inform the company’s broader regulatory strategy for the HeartBeam patch in the future,” HeartBeam explained. 

The significance of this research extends beyond a single device platform. Earlier and more accessible identification of coronary artery disease could potentially improve outcomes by allowing physicians to intervene before conditions escalate into heart attacks or other serious events. As healthcare systems increasingly emphasize preventive care and decentralized diagnostics, technologies capable of capturing high-quality cardiac data remotely may become increasingly important.

HeartBeam’s ongoing clinical research also highlights the growing convergence of medical devices, software analytics and patient-centered care models. By continuing to evaluate and expand the capabilities of its ECG platform, the company is seeking to position itself within a rapidly evolving segment of cardiac monitoring focused on portability, accessibility and earlier detection.

For more information, visit www.HeartBeam.com.

NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Identifies High-Priority Rare Earth Targets at Ontario’s Hopkins Project as Global Demand for Critical Minerals Accelerates

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

  • Powermax Minerals has completed a desktop study identifying multiple high-priority rare earth element (“REE”) exploration targets at its Hopkins REE Project in northeastern Ontario.
  • The study integrated geological, geophysical, geochemical, and historical datasets to define structurally controlled areas that may host REE mineralization.
  • Powermax plans a phased exploration program including mapping, sampling, airborne surveys, and potentially drilling, subject to exploration results and permits.
  • The company continues to build a North American portfolio of rare earth assets across Canada and the United States as rise in demand for REEs used in electric vehicles, renewable energy systems, and defense technologies, drives growing call for domestic critical mineral supply chains.

Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF), a Canadian mineral exploration company focused on rare earth projects, has identified several priority exploration targets at its Hopkins Rare Earth Element Project in Ontario following completion of a comprehensive desktop study designed to guide future field activities (https://nnw.fm/mIHT1) (https://ibn.fm/VTpDs).

The study provides a technical framework for the next phase of exploration at the Hopkins property, highlighting multiple areas where geological, geochemical, and geophysical indicators converge to suggest potential for rare earth element mineralization.

Prepared by geophysicist and geospatial data scientist Shahab Tavakoli, P.Geo., the study evaluated publicly available geological information, airborne magnetic and radiometric surveys from the Ontario Geological Survey, gravity data, and historical exploration records covering the Clay-Howells alkaline intrusive complex.

The Hopkins REE Project consists of 13 mineral claims covering approximately 6,145 hectares in Ontario’s Cochrane District, roughly 45 kilometres north-northeast of Kapuskasing. The property lies within the Kapuskasing Structural Zone, a geological corridor that hosts rare earth-bearing alkaline intrusive systems and has attracted interest for critical mineral exploration.

The analysis ranked Block A of the property as the highest-priority area for follow-up work. Within Block A, five target zones designated A1 through A5 were identified as areas where favorable structural features coincide with anomalous geochemical and geophysical signatures.

Target A1, located along the northern bank of the Kapuskasing River in the southern portion of Block A, received the highest ranking in the study. The target is interpreted as an area where favorable geological structures overlap with indicators associated with REE mineralization. Recommended follow-up activities include detailed geological mapping, rock sampling, and potential soil geochemistry to better define the extent of the target corridor.

Block B was ranked as the project’s second-priority exploration area. Two targets, B1 and B2, were identified along the margin of the intrusive complex where east-northeast trending structures are interpreted to support localized rare earth potential.

The study utilized a Weight-of-Evidence model to assess REE prospectivity by examining the relationship between historical total rare earth oxide values and geophysical signatures, including elevated thorium-to-potassium ratios, uranium signatures, gravity responses, and magnetic anomalies. The combined data suggests that rare earth mineralization may be controlled by structural pathways and late-stage alkaline and carbonatitic geological processes. However, the findings remain preliminary, with no current mineral resource estimate.

To advance the project, Powermax intends to undertake a phased exploration program, subject to funding, permitting, seasonal conditions, and final program design. Planned work includes airborne magnetic, very low frequency (“VLF”), and radiometric surveys, along with geological mapping, prospecting, targeted rock sampling, soil geochemistry, and ground verification of identified anomalies. Future trenching or drilling may be considered depending on exploration results.

Chief Executive Officer Paul Gorman said the study provides the company with a structured approach for evaluating the property and prioritizing the strongest targets for field verification.

The Hopkins project represents one component of Powermax’s broader strategy of developing a portfolio of rare earth assets in North America. In addition to Hopkins, the company holds options to acquire interests in the Cameron REE Project in British Columbia and the Atikokan REE Project in Ontario, and holds a 100% interest in the Ogden Bear Lodge Project in Wyoming.

Global demand for rare earth elements is expected to increase substantially over the coming decade as electrification and renewable energy deployment accelerate. At the same time, concerns about supply chain concentration remain a strategic issue because China currently dominates a significant portion of global rare earth mining and processing capacity. This supply imbalance has prompted governments in North America and other regions to call for the development of domestic critical mineral projects. In the United States, initiatives including the Defense Production Act have been used to encourage investment in rare earth supply chains through grants, financing support, and strategic procurement programs.

For more information, visit the company’s website at www.PowermaxMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to PWMXF are available in the company’s newsroom at https://ibn.fm/PWMXF

Exploration Target Cautionary Statement

The exploration targets discussed are conceptual, and there is currently not enough data to confirm a mineral resource. Further exploration may not yield successful results.

Earth Science Tech Inc. (ETST) Signals Strong Confidence with Aggressive Q1 Share Buybacks

  • Aggressive repurchase of its own stock by Earth Science Tech, a growing holding company focused on various aspects of the healthcare industry,  reflects management’s growing internal confidence in the company’s future trajectory.
  • Over 3 million shares of common stock have been repurchased in current fiscal quarter, a significant acceleration in buybacks.
  • Reduction in share dilution can consolidate existing equity and potentially boost earnings per share (“EPS”).

Earth Science Tech (OTC: ETST) is capturing the attention of the micro-cap market following a significant acceleration of its share repurchase program. Recent market data indicates that the company is aggressively buying back its own stock, a strategic corporate move that typically signals strong internal confidence in a company’s financial health, cash flow, and future trajectory.

According to current disclosures, Earth Science Tech has been highly active in its buyback program during its current fiscal first quarter of 2027. Over the course of this recent quarter, the company has successfully repurchased a total of 3,150,392 shares of its common stock.

What makes this figure particularly notable is the sheer velocity of the repurchases compared to historical data. To put this recent quarter into perspective, the 3.15 million shares bought back in just the first three months of Fiscal Q1 2027 represent over 83% of the total volume of shares the company purchased over the entire 12-month period of the preceding fiscal year ending 2026.

From a third-party analytical standpoint, when a company buys back more than four-fifths of its previous year’s total in a single quarter, it sends a distinct and bullish message to the market. Share repurchases of this magnitude generally highlight two key factors for investors:

  • Reduction of Outstanding Shares: By repurchasing over 3.15 million shares, ETST decreases the total number of outstanding shares in the open market, which can consolidate existing equity and potentially boost earnings per share (“EPS”).
  • Management Conviction: Accelerating a buyback program at this pace usually indicates that management and the board of directors believe the stock is currently undervalued by the market, and that investing capital directly back into the company yields a strong return on investment.

Earth Science Tech’s willingness to deploy capital into its own stock at such an accelerated rate is an indicator that current and prospective investors should watch closely. As ETST moves further into fiscal 2027, the market will be eager to see if this aggressive pace of share accumulation continues.

Data regarding Earth Science Tech, Inc.’s (ETST) outstanding shares, security details, and recent buyback activities can be verified directly via OTC Markets.

For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST

MindWave Innovations Inc. (NYSE American: APUS) Is Building an Ecosystem Designed to Unlock the Full Potential of Digital Asset Treasury Management

  • Institutional investors are increasingly looking beyond simply holding digital assets and are exploring strategies that can generate yield, improve liquidity and enhance treasury efficiency.
  • MindWave Innovations has built an ecosystem that integrates MindChain, Validator Nodes, AI Yield Engine, Treasury Wallet infrastructure and Real-World Asset (“RWA”) initiatives to support institutional digital asset adoption.
  • The company’s platform is designed to bridge traditional finance and blockchain technology by combining treasury management, AI-driven yield generation, asset tokenization and decentralized financial infrastructure.

Holding digital assets was once largely viewed as a passive strategy centered on long-term appreciation, inflation protection and portfolio diversification. Today, however, institutional investors are increasingly focused on a different objective: generating productive returns from digital asset holdings while maintaining the oversight, security and liquidity standards expected in traditional finance.

That shift is driving growing interest that can help institutions actively manage digital assets rather than simply store them. Strategies such as staking, AI-driven yield optimization and treasury management solutions are emerging as important tools for organizations seeking to improve capital efficiency and unlock additional value from their digital asset reserves.

Staking allows participants to earn rewards by helping secure blockchain networks and validate transactions, while AI-powered systems can analyze market conditions and dynamically allocate capital across yield-generating opportunities. At the same time, modern treasury platforms are helping institutions manage liquidity, monitor risk and streamline digital asset operations in an increasingly complex financial environment.

Positioned at the intersection of these trends is MindWave Innovations (NYSE American: APUS), a digital asset company focused on providing institutional-grade treasury infrastructure for the evolving digital asset economy.

The company aims to help corporations and institutional investors securely hold, manage, and generate yield on Bitcoin reserves. Rather than offering a single product, MindWave has built an integrated ecosystem designed to connect digital asset treasury management, blockchain infrastructure, AI-powered analytics and decentralized financial services.

Built on top of that infrastructure are four primary application verticals that expand the utility of the ecosystem into real-world markets:

MindChain: The company’s Layer 2 blockchain network designed to provide scalable transaction processing, ecosystem interoperability and support for decentralized applications and tokenized financial services.

Validator Nodes: A decentralized validation framework that helps secure the network, verify transactions and support staking-based participation across the ecosystem.

AI Yield Engine: An autonomous, AI-powered system that continuously analyzes market conditions, allocates capital and seeks to optimize risk-adjusted returns across digital asset strategies.

Treasury Wallet: A secure treasury management solution designed to help institutions manage digital assets, oversee liquidity, monitor activity and support yield-generating treasury operations from a centralized interface.

Beyond its core infrastructure, MindWave is also expanding its ecosystem through Real-World Asset (“RWA”) initiatives, which are designed to bridge traditional assets with blockchain-based financial networks. The company envisions tokenizing assets such as real estate, commodities and other value-bearing holdings, allowing them to be represented and managed on-chain with greater transparency, accessibility and efficiency. As institutional interest in asset tokenization continues to grow, RWA solutions are increasingly being viewed as a potential pathway for unlocking liquidity, broadening participation and connecting traditional finance with decentralized financial infrastructure.

Together, these components create the operational backbone of the MindWaveDAO ecosystem, allowing corporations and institutional participants to move beyond simply holding digital assets and toward actively managing them as productive treasury assets.

The company describes this approach as bridging traditional treasury management with blockchain-enabled financial infrastructure. By combining secure custody, decentralized validation, AI-driven capital allocation and treasury oversight tools, MindWave is building an ecosystem intended to support the next generation of institutional digital asset adoption.

For more information, visit the company’s website at www.MindWaveDAO.com.

NOTE TO INVESTORS: The latest news and updates relating to APUS are available in the company’s newsroom at https://ibn.fm/APUS

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Launches Lead Commercial Software Intox AI(TM) for Multiple Forms of Intoxication Detection

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

  • The platform is designed to detect cocaine, cannabis, alcohol, narcotics, psychedelics, and human fatigue using voice analysis and artificial intelligence.
  • MindBio is preparing to deploy the software through Edge AI kiosk systems targeted at safety-critical industries.
  • The company is pursuing commercialization opportunities in mining, aviation, construction, transportation, and law enforcement markets.
  • MindBio’s technology offers a non-invasive and affordable alternative to traditional drug and alcohol testing methods.
  • The launch represents a key step in the company’s transition from research and clinical development toward commercial implementation.

MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF), a biotechnology company, has launched Intox AI(TM), its flagship enterprise software platform designed to detect drug use, alcohol intoxication, and human fatigue, through voice analysis powered by artificial intelligence. The announcement marks an important milestone in the company’s commercialization strategy as it moves toward deployment of its first Edge AI kiosk prototypes, which are expected to be completed during the current quarter (https://ibn.fm/GrITB).

According to MindBio, Intox AI(TM) is designed to analyze speech patterns in real time and identify indicators associated with multiple neurologically active substances, including cocaine, cannabis, alcohol, psychedelics, and narcotics. The platform is also being developed to assess human fatigue, a factor that remains a significant safety concern in many industrial environments.

The company believes the technology could address a growing need for scalable impairment screening in industries where worker alertness and sobriety are essential. Mining operations, aviation, construction, heavy transportation, and law enforcement, are among the sectors being targeted for future commercialization. These industries often operate under strict workplace safety requirements and regulatory frameworks that mandate drug and alcohol testing programs.

Traditional testing methods typically rely on breathalyzers, saliva tests, or laboratory analysis, approaches that can be time-consuming, require specialized equipment, involve ongoing consumable costs, and create operational challenges when screening large numbers of workers.

MindBio’s approach seeks to simplify that process by using voice as the primary diagnostic input. The company’s system analyzes millions of data points extracted from speech and generates an assessment within seconds. When scaled, such a platform could offer organizations a much faster and less intrusive screening method than many existing alternatives.

The launch of Intox AI(TM) builds on several years of research and development focused on acoustic biomarkers. MindBio has been conducting clinical studies examining how intoxication and impairment affect speech characteristics. Through those studies, the company has developed machine-learning models designed to identify measurable changes in voice patterns associated with substance use and cognitive impairment.

According to the company, its predictive models have been trained on more than 50 million data points and analyze over 140 acoustic parameters extracted from human speech. Management states that this dataset has helped establish a proprietary foundation for both consumer and enterprise applications.

The company’s technology portfolio now extends beyond alcohol detection alone. MindBio previously introduced Booze AI, a consumer-focused application that estimates blood alcohol concentration using voice analysis and behavioral inputs. Intox AI(TM) expands those capabilities into enterprise markets while adding detection capabilities across multiple substance categories and fatigue-related conditions.

The company is pursuing a business model that combines hardware deployment with recurring software revenue. Its Edge AI kiosks are being designed for on-site use in industrial environments, enabling workers to complete voice-based assessments through touchless systems that perform analysis locally and provide compliance-ready reporting.

Beyond workplace safety, management has identified potential future applications in telehealth, remote monitoring, and broader health prediction technologies. Because the underlying platform analyzes physiological and cognitive indicators reflected in speech, the company believes its technology may be adaptable across multiple healthcare and wellness use cases.

For more information, visit the company’s website at www.MindBioTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to MBQIF are available in the company’s newsroom at https://ibn.fm/MBQIF

Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) Invests in Orbital Power Grid as Space Infrastructure Era Begins

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

  • The demand driving key space services is structural not speculative.
  • Mantis Space is developing what it described as the world’s first power grid in space.
  • Planet Ventures completed a $200,000 strategic equity investment in Mantis Space, marking the company’s first deployment of capital into the sector.

The space industry is no longer just launching satellites; it is beginning to service, fuel and power them in orbit, and the shift from concept to commercial reality is accelerating. After years of theoretical roadmaps, capabilities such as on-orbit refueling, debris removal, in-space assembly and orbital power distribution are now drawing serious capital, government contracts and engineering milestones. Into this pivotal moment, Planet Ventures (CSE: PXI) (OTC: PNXPF) has made its first move into the space economy, backing Mantis Space, a company working to build the first power grid in orbit.

The demand driving these services is structural not speculative. Novaspace’s 2026 small satellite market report forecasts 16,900 satellites under 500 kg. will be launched between 2026 and 2035, averaging roughly 640 kg. of payload deployed daily. As constellations scale, operators face mounting pressure to extend satellite lifespans, reduce the cost and weight of onboard power systems, and manage orbital congestion. 

Traditional satellite architecture requires each spacecraft to carry its own solar panels and batteries for the entire duration of its mission, an expensive, mass-intensive design constraint that limits performance and economic viability. The emerging space-to-space economy is evolving specifically to address these constraints by turning space infrastructure into shared, persistent services rather than single-use hardware.

For example, Astroscale U.S. is set to conduct what will be the first-ever commercial refueling of a U.S. Department of Defense satellite in geostationary orbit, with a mission manifested to launch in the summer of 2026. In terms of debris management, Astroscale’s ELSA-M program, designed as the world’s first commercial end-of-life removal service for prepared satellites, is advancing toward a 2026 launch following a launch services agreement signed with Isar Aerospace in March 2026. 

Meanwhile, analysts and industry groups are pointing to the need for standardized servicing interfaces, shared logistics infrastructure and persistent in-orbit capabilities, a recognition that orbital operations are maturing into something much more analogous to a managed industrial ecosystem than a series of independent launches. A December 2025 analysis from NASA’s Consortium for Space Mobility and ISAM Capabilities identified GEO satellite refueling as one of the most practically valuable near-term applications of on-orbit servicing, calling for focused investment and coordinated policy to accelerate adoption.

Mantis Space is building directly into this gap. The company is developing what it describes as the world’s first power grid in space, a scalable satellite constellation optimized for continuous solar energy collection and wireless redistribution through proprietary laser-based technology. The system is designed so that satellites built to receive power from the Mantis network require fewer onboard solar panels and batteries, resulting in smaller, lighter and less expensive spacecraft. 

The analogy Planet Ventures uses in this scenario is compelling: In the early days of the automobile, drivers had to carry all the fuel they needed for a trip; the gas station was the disruptive invention that changed vehicle design entirely. Mantis positions orbital energy distribution as that same structural enabler for the next generation of space operations. The company has already attracted meaningful institutional confidence: Its headquarters expansion in Albuquerque, New Mexico, is supported by $2.5 million through New Mexico’s Local Economic Development Act program and an additional $500,000 from the city of Albuquerque, reflecting public-sector conviction in its long-term impact.

Planet Ventures completed a $200,000 strategic equity investment in Mantis Space in February 2026, marking the company’s first deployment of capital into the space sector. The investment was made in exchange for 49,313 shares at $4.0557 per share and was part of a broader financing round for Mantis. 

For Planet Ventures, the transaction is consistent with its stated mandate as a publicly traded investment issuer focused on high-growth, disruptive sectors, giving ordinary shareholders exposure to private space startups that would typically be accessible only to institutional venture capital. 

“The commercialization of space is accelerating rapidly, and infrastructure solutions such as orbital energy distribution are foundational to the next phase of growth,” said Planet Ventures CEO Etienne Moshevich. “We believe Mantis Space is building in a strategically critical segment of the space economy, and we are excited to support their development.”

The investment also aligns Planet Ventures with a theme that is becoming central to the space industry’s next chapter. As the company notes, the most attractive opportunities in space remain locked inside private companies inaccessible to most individual investors, and Planet is built to bridge that gap. By positioning early in orbital infrastructure rather than in launch or earth observation, segments that are already maturing and increasingly commoditized, Planet Ventures is placing its thesis at the intersection of energy, satellite operations and in-space logistics. If Mantis delivers on its vision, Planet Ventures will have established a foothold in what could become one of the most critical utility businesses of the coming decade.

For more information, visit www.PlanetVenturesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to PNXPF are available in the company’s newsroom at https://ibn.fm/PNXPF

Disclaimer

Investor Brand Network (“We” or “Us”) are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Planet Ventures Inc. will make aggregate payments of $100,000  to us to provide marketing services for a term of 1 year. This article is informational only and is solely for use by prospective investors in determining whether to seek additional information. This does not constitute an offer to sell or a solicitation of an offer to buy any securities. Our stock profiles are intended to highlight certain companies for your further investigation; they are not stock recommendations or constitute an offer or sale of the referenced securities. The securities issued by the companies we profile should be considered high risk; if you do invest despite these warnings, you may lose your entire investment. Please do your own research before investing, including reading the companies’ SEDAR+ and SEC filings, press releases, and risk disclosures.

Forward-Looking Statements

This document contains forward-looking statements within the meaning of applicable securities legislation. Such statements include, without limitation, statements regarding: Planet Ventures’ investment strategy and objectives; anticipated developments in the commercial space industry, including the growth of orbital energy and space robotics markets; the projected growth of the global space economy; Planet Ventures’ expectations regarding the strategic importance of its investments in Mantis Space and General Astronautics; the anticipated role of orbital energy technologies and robotic servicing systems in future in-orbit operations; and the potential for these technologies to become foundational to the next generation of commercial space activity.

Forward-looking statements are not guarantees of future performance. Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements contained in this document are made as of the date hereof and Planet Ventures undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.

Risk Factors

Investing in Planet Ventures and its portfolio companies involves a high degree of risk. The following is a summary of key risk factors. This is not an exhaustive list, and additional risks may exist that are not currently known:

  • Early-Stage Investment Risk. Portfolio companies have limited operating histories and are pre-revenue. Investments are speculative and may result in a total loss of capital.
  • Technology Risk. The orbital energy and lunar habitation technologies underlying the Company’s investments are unproven at commercial scale and may not be successfully developed or deployed.
  • Regulatory Risk. Space sector operations require licenses and approvals from domestic and international regulatory bodies. Failure to obtain or maintain these could materially delay or prevent operations.
  • Market Risk. Commercial demand for in-space power systems and lunar services has not been established at scale. Projected market growth may not be realized within anticipated timeframes.
  • Liquidity Risk. Investments in private, early-stage companies are illiquid. There is no guarantee of a market for these securities or the ability to exit on favorable terms.
  • Capital Risk. Portfolio companies may require additional funding that may not be available, or may be available only on dilutive or restrictive terms.
  • Macroeconomic and Geopolitical Risk. Adverse macroeconomic conditions or geopolitical developments could disrupt the Company’s investment strategy or the operations of portfolio companies.
  • Key Personnel Risk. The Company’s performance depends in part on retaining key personnel and advisors. Loss of key individuals could adversely affect the Company’s operations and investment activities.

Greenland Energy Company (NASDAQ: GLND) Outlines Fully Funded Plan to Drill East Greenland’s Jameson Land Basin

  • The centerpiece of Greenland Energy’s investment thesis is the Jameson Land Basin itself.
  • The earn-in structure is a key feature of Greenland Energy’s model.
  • The company’s capital position is equally central to the near-term execution story.

With a 2026 drilling window fast approaching and $70 million in fresh capital already secured, Greenland Energy (NASDAQ: GLND) is making a compelling argument that the Jameson Land Basin in East Greenland, one of the largest undeveloped Arctic hydrocarbon positions in the world, is no longer a story about geological potential but about execution. In an updated investor presentation, the Houston-based energy exploration company outlines in detail its proposed strategy to advance exploration of the Jameson Land Basin through modern technology, a clearly defined earn-in structure and a set of near-term drilling catalysts that management believes are achievable within the current calendar year.

The centerpiece of Greenland Energy’s investment thesis is the Jameson Land Basin itself, a roughly 2.1-million-acre position in East Greenland covered by three exclusive exploration and exploitation licenses. According to the company, an independent engineering estimate places the basin’s gross unrisked 3U prospective recoverable oil at up to approximately 13.0 billion barrels. While that figure represents prospective resources that have not been confirmed by drilling, the sheer scale of the estimate, combined with what the company describes as more than $275 million in historical investment in the basin adjusted to today’s dollars, helps explain why Greenland Energy believes the opportunity warrants serious attention. The company has identified 58 prospective drill sites across the basin’s approximately 1,800 kilometers of existing 2D seismic coverage.

The historical foundation underpinning that resource estimate goes back decades. Between the 1970s and 1990, ARCO, the same company whose geological persistence ultimately led to the 1968 discovery of North America’s largest oil field, conducted extensive exploration in the Jameson Land Basin, including geological mapping, gravity and magnetic surveys, 2D seismic acquisition, surface seep analysis, and basin modeling. 

According to the company, ARCO internally viewed Jameson Land as one of its most significant undeveloped Arctic opportunities. What halted development was not geology but economics: The oil price collapse of the 1980s reduced project viability, and corporate restructuring ultimately curtailed ARCO’s exploration budgets. The basin remained undrilled. 

Fast-forward to 2014, when a company called White Flame was awarded the Jameson Land licenses and commissioned the first nongovernment reassessment of the basin since the 1990s, reprocessing historical 2D seismic data and completing Full Tensor Gradiometry and LiDAR work. In 2021, 80 Mile completed its acquisition of White Flame, consolidating control of the three exploration licenses. The current path to the drill bit was set in March 2025, when March GL, the entity through which Greenland Energy holds it earn-in rights, agreed to fund the first two exploration wells.

The earn-in structure is a key feature of Greenland Energy’s model. The company has rights to earn up to 70% working interest across the Jameson Land license position upon the completion of two exploration wells: OPW-1 and OPW-6. The structure is milestone driven: 50% working interest is earned upon completion of the first well, with the full 70% earned after the second. OPW-1 is targeted for the third quarter of 2026, with OPW-6 planned for the fourth quarter of 2026. 

That timeline is not theoretical; heavy equipment was mobilized to East Greenland by barge in October 2025, and by the first quarter of 2026, equipment was in place to begin road and pad construction leading to the planned drill site. Construction of a three-mile road to the drill site is planned as part of the current phase.

Greenland Energy’s ability to execute on that timeline rests heavily on its execution partners, and the updated presentation devotes significant attention to the team assembled for the OPW-1 and OPW-6 campaigns. Stampede Drilling is the primary drilling contractor, bringing Arctic-capable equipment and operational experience. Halliburton provides integrated services and well planning. IPT Well Solutions delivers engineering support and well planning services. Desgagnés, one of Canada’s most experienced Arctic marine operators, is handling logistics and Arctic shipping. The combination of a seasoned drilling contractor, one of the world’s largest oilfield services companies and a proven Arctic logistics operator is designed to address what the presentation itself acknowledges are formidable operational challenges: remote Arctic conditions, extreme weather, seasonal access windows and limited existing infrastructure.

The company’s capital position is equally central to the near-term execution story. In late April 2026, Greenland Energy closed a $70 million public offering, pricing 17.5 million shares at $4 per share with accompanying common warrants exercisable at $5, with ThinkEquity acting as sole placement agent. CEO Robert Price described the raise as fully funding the company’s exploration plan, stating it positions Greenland Energy to deploy capital into OPW-1 and OPW-6 procurement and secure mill capacity for long-lead materials. It also funds the mobilization of the equipment, crews and logistics needed to advance the program toward planned October 2026 drilling operations. Earlier this year, the company listed on NASDAQ with an implied enterprise valuation of approximately $215 million at closing.

One important element of the current opportunity that the presentation highlights is the regulatory context. Greenland has announced that it would stop issuing new hydrocarbon exploration licenses, meaning the existing Jameson Land licenses held through White Flame and 80 Mile are grandfathered, and no new entrants can secure similar rights to the basin. That structure effectively makes the Jameson Land license position a one-of-a-kind opportunity in today’s regulatory environment. 

As the global conversation around Arctic energy security intensifies, driven by geopolitical realignments and the strategic significance of untapped hydrocarbon resources in stable, allied jurisdictions, the combination of scale, historical validation, grandfathered license status and a fully funded near-term drilling campaign makes Greenland Energy’s updated investor presentation worth reading carefully.

For more information, visit the company’s website at www.GreenlandEnergyCo.com.

NOTE TO INVESTORS: The latest news and updates relating to GLND are available in the company’s newsroom at ibn.fm/GLND

Forward-Looking Statements

This communication contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained herein other than statements of present or historical fact, including, without limitation, statements regarding Greenland Energy Company’s (the “Company”) future financial performance, business strategy, operations, financial position, estimated revenues and losses, projected costs, prospects, plans, objectives of management, and expected benefits of the Company’s recent business combination, are forward-looking statements. Forward-looking statements are generally identified by the use of words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “project,” “forecast,” “potential,” “predict,” or the negative of these terms or similar expressions, although not all forward-looking statements contain such identifying words.

These forward-looking statements are based on management’s current expectations, assumptions and beliefs regarding future events and are based on information currently available to the Company. These statements involve a number of risks and uncertainties, many of which are difficult to predict and are beyond the Company’s control, and actual results may differ materially from those expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially include, among others: (i) Exploration and Geological Risks, including the Company’s status as a development-stage company with no operating history, revenues, or proved reserves; the inherent uncertainty in prospective resource estimates, including that the 13 billion barrel estimate is based on undiscovered accumulations with no certainty of discovery or commercial viability; geological complexity arising from limited seismic data coverage, pervasive igneous intrusions, faulting patterns, and significant Tertiary uplift creating thermal maturity uncertainty; the fact that the basin has never produced a commercial discovery despite decades of study dating back to the 1970s, and a 2008 USGS report stating less than a 10% chance of containing a technically recoverable hydrocarbon accumulation; and high-cost frontier exploration with estimated well costs of $40 million for the first well and $20 million for subsequent wells; (ii) Operational and Environmental Risks, including the challenges of operating in a remote Arctic location with extreme climate, harsh weather, limited daylight, no existing infrastructure, and seasonal access windows for equipment and personnel; drilling hazards such as blowouts, equipment failures, well control events, environmental releases, and accidents inherent in oil and gas operations; reliance on third-party contractors; and climate change scrutiny, as operations in Greenland face increasing opposition from environmental groups and institutional investors due to Arctic drilling concerns; (iii) Regulatory and Political Risks, including the 2021 Greenland drilling moratorium, and while licenses are grandfathered, future regulatory changes could jeopardize operations; geopolitical tensions, including U.S. interest in acquiring Greenland and Greenland’s internal independence movements that could affect operations; permit requirements, as drilling requires Environmental Impact Assessment approval and Field Activities Application approval from Greenlandic authorities; and forfeiture risk, as failure to meet drilling milestones could result in loss of the Company’s right to earn working interests; (iv) Financial and Capital Risks, including significant capital requirements and the need for substantial funding beyond current resources to complete the drilling program; commodity price volatility, as oil, gas, and NGL prices are highly volatile and will heavily influence project viability; a long development timeline during which market conditions may change significantly before potential production, unlike short-cycle shale projects; going concern uncertainty and substantial doubt about the Company’s ability to continue as a going concern without additional financing; and energy transition risk, as global demand for oil may decline due to electric vehicle adoption, renewable energy policies, and changing consumer preferences; and other risks and uncertainties as set forth in the Company’s Prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b)(4) under the Securities Act on April 29, 2026, in the section titled “Risk Factors”.

Forward-looking statements speak only as of the date they are made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

From Our Blog

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Targets a $393 Billion Heart Disease Problem with Epigenetics and AI

June 22, 2026

Heart disease has held the grim distinction of being the leading cause of death in the United States for decades, and despite advances in medicine, the problem is getting worse, not better. According to the American Heart Association (“AHA”), cardiovascular disease accounted for more than 940,000 deaths in the United States in 2022, maintaining its position […]

Rotate your device 90° to view site.